Stellar Biotechnologies caters to the essential molecule demands of pharmaceutical and immunodiagnostic markets.
Führungspositionen
Name & Titel
Biographie
Frank Oakes
CEO / President
Frank Oakes serves as the CEO / President of Stellar Biotechnologies.
Gregory T. Baxter Ph.D.
Executive Vice President of Corporate Development
Dr. Gregory T. Baxter, also known as Greg, Ph.D., has been an Executive Vice President of Corporate Development at Stellar Biotechnologies, Inc. since December 1, 2016. Dr. Baxter served as Director of Stellar Biotechnologies, Inc. since August 15, 2012 until December 1, 2016 and served as its Member of Scientific Advisory Board since June 6, 2014 until December 1, 2016. Dr. Baxter holds Ph.D. in Biochemistry and Molecular Biology from University of California.
Kathi Niffenegger CPA
CFO, Corporate Secretary & Principal Accounting Officer
Ms. Kathi Niffenegger, CPA, has been a Corporate Secretary of Stellar Biotechnologies, Inc. since June 2013 and its Chief Financial Officer since November 1, 2013 and also serves as its Principal Accounting Officer. Ms. Niffenegger is an experienced professional with more than 30 years in accounting and finance in a wide range of industries. She held the positions of U.S. Corporate Controller for Stellar since 2012. Ms. Niffenegger has been an outside CPA since 1999. She holds a BSBA from California State University.
Kathi Niffenegger
Chief Financial Officer
Kathi Niffenegger serves as the Chief Financial Officer of Stellar Biotechnologies.
Mike Sampat
Board of Directors
Mike Sampat serves as the Board of Directors of Stellar Biotechnologies.
Lassen Sie Stellar Biotechnologies wissen, dass Sie dort arbeiten möchten
Sagen Sie Stellar Biotechnologies, dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt Stellar Biotechnologies die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.
Gleichberechtigungs BewertungWie positiv bewerten Frauen ihre Gesamterfahrung mit Stellar Biotechnologies
N/A
Herkunftsvielfalts BewertungWie positiv bewerten Minderheiten ihre Gesamterfahrung mit Stellar Biotechnologies